Curis
CRIS
#11190
Rank
C$2.32 M
Marketcap
C$0.96
Share price
-5.38%
Change (1 day)
-55.05%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -C$12.48 Million

According to Curis's latest financial reports the company's current earnings are C$4.31 Million. In 2025 the company made an earning of -C$7.7 Million, an increase over its 2024 earnings that were of -C$60.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$12.48 Million62.16%
2025 -C$7.7 Million-87.38%
2024 -C$60.98 Million-5.77%
2023 -C$64.71 Million-13.1%
2022 -C$74.46 Million27.52%
2021 -C$58.4 Million65.09%
2020 -C$35.37 Million-9.1%
2019 -C$38.91 Million-4.73%
2018 -C$40.84 Million-41.95%
2017 -C$70.35 Million-14.37%
2016 -C$82.16 Million3.55%
2015 -C$79.34 Million271.52%
2014 -C$21.36 Million76.64%
2013 -C$12.09 Million
2011 -C$10.27 Million27.76%
2010 -C$8.04 Million-43.87%
2009 -C$14.32 Million-23.44%
2008 -C$18.71 Million56.66%
2007 -C$11.94 Million-16.71%
2006 -C$14.34 Million-36.92%
2005 -C$22.73 Million156.25%
2004 -C$8.87 Million-37.24%
2003 -C$14.13 Million-93.34%
2002 -C$0.22 Billion86.79%
2001 -C$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$9.84 B-81,859.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.97 B-141,080.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-C$88.21 Million 632.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$1.47 B-12,356.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.47 Billion 3,756.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-C$31.73 Million 163.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-C$0.14 Billion 1,025.71%๐Ÿ‡บ๐Ÿ‡ธ USA